| 1.93 0.23 (13.53%) | 11-10 11:08 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.24 |
1-year : | 4.19 |
| Resists | First : | 2.77 |
Second : | 3.58 |
| Pivot price | 1.97 |
|||
| Supports | First : | 1.46 | Second : | 1.21 |
| MAs | MA(5) : | 1.71 |
MA(20) : | 2.17 |
| MA(100) : | 4.78 |
MA(250) : | 8.14 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 22.1 |
D(3) : | 10.4 |
| RSI | RSI(14): 44.5 |
|||
| 52-week | High : | 32.54 | Low : | 1.46 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AMIX ] has closed below upper band by 30.1%. Bollinger Bands are 70.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 39 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.75 - 1.76 | 1.76 - 1.77 |
| Low: | 1.51 - 1.52 | 1.52 - 1.53 |
| Close: | 1.68 - 1.7 | 1.7 - 1.71 |
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Tue, 10 Nov 2026
With $7.7M in cash, Autonomix Medical (AMIX) flags substantial going-concern doubt. - Stock Titan
Wed, 16 Sep 2026
A former Medtronic FDA lawyer joins Autonomix’s board after work on more than 27 acquisitions. - Stock Titan
Tue, 01 Sep 2026
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 - GlobeNewswire
Tue, 25 Aug 2026
Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why - TradingView
Mon, 24 Aug 2026
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules - GlobeNewswire
Thu, 06 Aug 2026
AMIX Stock Price and Chart — NASDAQ:AMIX - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 2 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 5.7 (%) |
| Held by Institutions | 5 (%) |
| Shares Short | 59 (K) |
| Shares Short P.Month | 61 (K) |
| EPS | -39.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.82 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -157.9 % |
| Return on Equity (ttm) | -316 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -8.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.38 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|